Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 197

    1.

    A randomized, double-blind, safety and tolerability study to assess the ophthalmic and renal effects of tafenoquine 200 mg weekly versus placebo for 6 months in healthy volunteers.

    Leary KJ, Riel MA, Roy MJ, Cantilena LR, Bi D, Brater DC, van de Pol C, Pruett K, Kerr C, Veazey JM Jr, Beboso R, Ohrt C.

    Am J Trop Med Hyg. 2009 Aug;81(2):356-62.PMID: 19635898 [PubMed - indexed for MEDLINE]Related articles

    2.

    Drug dosing in patients with impaired renal function.

    Brater DC.

    Clin Pharmacol Ther. 2009 Nov;86(5):483-9. Epub 2009 Jul 22. Review.PMID: 19626002 [PubMed - indexed for MEDLINE]Related articles

    3.

    Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study.

    Krum H, Swergold G, Curtis SP, Kaur A, Wang H, Smugar SS, Weir MR, Laine L, Brater DC, Cannon CP.

    J Hypertens. 2009 Apr;27(4):886-93.PMID: 19516186 [PubMed - indexed for MEDLINE]Related articles

    4.

    Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program.

    Krum H, Curtis SP, Kaur A, Wang H, Smugar SS, Weir MR, Laine L, Brater DC, Cannon CP.

    Eur J Heart Fail. 2009 Jun;11(6):542-50. Epub 2009 Apr 19.PMID: 19380329 [PubMed - indexed for MEDLINE]Related articles

    5.

    Factors associated with exacerbation of heart failure include treatment adherence and health literacy skills.

    Murray MD, Tu W, Wu J, Morrow D, Smith F, Brater DC.

    Clin Pharmacol Ther. 2009 Jun;85(6):651-8. Epub 2009 Mar 4.PMID: 19262464 [PubMed - indexed for MEDLINE]Related articles

    7.

    Viewpoint: infusing professionalism into a school of medicine: perspectives from the dean.

    Brater DC.

    Acad Med. 2007 Nov;82(11):1094-7.PMID: 17971698 [PubMed - indexed for MEDLINE]Related articles

    8.

    Pharmacist intervention to improve medication adherence in heart failure: a randomized trial.

    Murray MD, Young J, Hoke S, Tu W, Weiner M, Morrow D, Stroupe KT, Wu J, Clark D, Smith F, Gradus-Pizlo I, Weinberger M, Brater DC.

    Ann Intern Med. 2007 May 15;146(10):714-25.PMID: 17502632 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Medication and dietary compliance beliefs in heart failure.

    Bennett SJ, Lane KA, Welch J, Perkins SM, Brater DC, Murray MD.

    West J Nurs Res. 2005 Dec;27(8):977-93; discussion 994-9.PMID: 16275694 [PubMed - indexed for MEDLINE]Related articles

    10.

    Renal effects of the cyclooxygenase-inhibiting nitric oxide donator AZD3582 compared with rofecoxib and naproxen during normal and low sodium intake.

    Huledal G, Jonzon B, Malmenäs M, Hedman A, Andersson LI, Odlind B, Brater DC.

    Clin Pharmacol Ther. 2005 May;77(5):437-50.PMID: 15900289 [PubMed - indexed for MEDLINE]Related articles

    11.

    Association between adherence measurements of metoprolol and health care utilization in older patients with heart failure.

    Tu W, Morris AB, Li J, Wu J, Young J, Brater DC, Murray MD.

    Clin Pharmacol Ther. 2005 Mar;77(3):189-201.PMID: 15735613 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Methodology of an ongoing, randomized, controlled trial to improve drug use for elderly patients with chronic heart failure.

    Murray MD, Young JM, Morrow DG, Weiner M, Tu W, Hoke SC, Clark DO, Stroupe KT, Wu J, Deer MM, Bruner-England TE, Sowinski KM, Smith FE, Oldridge NB, Gradus-Pizlo I, Murray LL, Brater DC, Weinberger M.

    Am J Geriatr Pharmacother. 2004 Mar;2(1):53-65.PMID: 15555479 [PubMed - indexed for MEDLINE]Related articles

    13.

    A conceptual framework to study medication adherence in older adults.

    Murray MD, Morrow DG, Weiner M, Clark DO, Tu W, Deer MM, Brater DC, Weinberger M.

    Am J Geriatr Pharmacother. 2004 Mar;2(1):36-43. Review.PMID: 15555477 [PubMed - indexed for MEDLINE]Related articles

    14.

    Randomized trial of AT-1015 for treatment of intermittent claudication. A novel 5-hydroxytryptamine antagonist with no evidence of efficacy.

    Hiatt WR, Hirsch AT, Cooke JP, Olin JW, Brater DC, Creager MA.

    Vasc Med. 2004 Feb;9(1):18-25.PMID: 15230484 [PubMed - indexed for MEDLINE]Related articles

    15.

    Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal study.

    MacFadyen RJ, Gorski JC, Brater DC, Struthers AD.

    Br J Clin Pharmacol. 2004 May;57(5):622-31.PMID: 15089816 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Health care and medication costs and use among older adults with heart failure.

    Stroupe KT, Teal EY, Weiner M, Gradus-Pizlo I, Brater DC, Murray MD.

    Am J Med. 2004 Apr 1;116(7):443-50.PMID: 15047033 [PubMed - indexed for MEDLINE]Related articles

    17.

    Association between adherence to diuretic therapy and health care utilization in patients with heart failure.

    Chui MA, Deer M, Bennett SJ, Tu W, Oury S, Brater DC, Murray MD.

    Pharmacotherapy. 2003 Mar;23(3):326-32.PMID: 12627931 [PubMed - indexed for MEDLINE]Related articles

    18.

    Anti-inflammatory agents and renal function.

    Brater DC.

    Semin Arthritis Rheum. 2002 Dec;32(3 Suppl 1):33-42. Review.PMID: 12528072 [PubMed - indexed for MEDLINE]Related articles

    19.

    Loop diuretics: from the Na-K-2Cl transporter to clinical use.

    Shankar SS, Brater DC.

    Am J Physiol Renal Physiol. 2003 Jan;284(1):F11-21. Review.PMID: 12473535 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Diuretic therapy in congestive heart failure.

    Brater DC.

    Congest Heart Fail. 2000 May;6(4):197-201.PMID: 12147953 [PubMed - as supplied by publisher]Related articles

    21.

    Controversies in COX-2 selective inhibition.

    Simon LS, Smolen JS, Abramson SB, Appel G, Bombardier C, Brater DC, Breedveld FC, Brune K, Burmester GR, Crofford LJ, Dougados M, DuBois RN, Fitzgerald GA, Frishman W, García Rodríguez LA, Hochberg MC, Kalden JR, Laine L, Langman MJ, Prescott SM, van de Putte LB, Whelton A, White WB, Willaims GH.

    J Rheumatol. 2002 Jul;29(7):1501-10. Review. No abstract available. PMID: 12136912 [PubMed - indexed for MEDLINE]Related articles

    22.

    Measurement of renal function during drug development.

    Brater DC.

    Br J Clin Pharmacol. 2002 Jul;54(1):87-95. Review. No abstract available. PMID: 12100232 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Renal effects of cyclooxygyenase-2-selective inhibitors.

    Brater DC.

    J Pain Symptom Manage. 2002 Apr;23(4 Suppl):S15-20; discussion S21-3. Review.PMID: 11992745 [PubMed - indexed for MEDLINE]Related articles

    24.

    BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy.

    Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, Dyer F, Gomez M, Bennett D, Ticho B, Beckman E, Abraham WT.

    Circulation. 2002 Mar 19;105(11):1348-53. Erratum in: Circulation 2002 Sep 24;106(13):1743. PMID: 11901047 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Social support and health-related quality of life in chronic heart failure patients.

    Bennett SJ, Perkins SM, Lane KA, Deer M, Brater DC, Murray MD.

    Qual Life Res. 2001;10(8):671-82.PMID: 11871588 [PubMed - indexed for MEDLINE]Related articles

    26.

    Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure.

    Murray MD, Deer MM, Ferguson JA, Dexter PR, Bennett SJ, Perkins SM, Smith FE, Lane KA, Adams LD, Tierney WM, Brater DC.

    Am J Med. 2001 Nov;111(7):513-20.PMID: 11705426 [PubMed - indexed for MEDLINE]Related articles

    27.

    Renal effects of cyclooxygenase-2 selective inhibitors.

    Harris CJ, Brater DC.

    Curr Opin Nephrol Hypertens. 2001 Sep;10(5):603-10. Review.PMID: 11496053 [PubMed - indexed for MEDLINE]Related articles

    28.

    Diuretics in congestive heart failure which one, what dose, and does it make a difference?

    Brater DC.

    Cardiovasc J S Afr. 2000 Apr;11(2):61-64. No abstract available. PMID: 11447465 [PubMed - as supplied by publisher]Related articles

    29.

    Effect of albumin-furosemide mixtures on response to furosemide in cirrhotic patients with ascites.

    Brater DC, Chalasani N, Gorski JC, Horlander JC Sr, Craven R, Hoen H, Maya J.

    Trans Am Clin Climatol Assoc. 2001;112:108-15; discussion 116. No abstract available. PMID: 11413770 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Reliability and validity of the compliance belief scales among patients with heart failure.

    Bennett SJ, Perkins SM, Lane KA, Forthofer MA, Brater DC, Murray MD.

    Heart Lung. 2001 May-Jun;30(3):177-85.PMID: 11343003 [PubMed - indexed for MEDLINE]Related articles

    31.

    Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients.

    Chalasani N, Gorski JC, Horlander JC Sr, Craven R, Hoen H, Maya J, Brater DC.

    J Am Soc Nephrol. 2001 May;12(5):1010-6.PMID: 11316860 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Renal effects of COX-2-selective inhibitors.

    Brater DC, Harris C, Redfern JS, Gertz BJ.

    Am J Nephrol. 2001 Jan-Feb;21(1):1-15. Review.PMID: 11275626 [PubMed - indexed for MEDLINE]Related articles

    33.

    Medieval contributions to the search for truth in clinical medicine.

    Daly WJ, Brater DC.

    Perspect Biol Med. 2000 Summer;43(4):530-40. No abstract available. PMID: 11058989 [PubMed - indexed for MEDLINE]Related articles

    34.

    Healthcare costs of patients with heart failure treated with torasemide or furosemide.

    Stroupe KT, Forthofer MM, Brater DC, Murray MD.

    Pharmacoeconomics. 2000 May;17(5):429-40.PMID: 10977385 [PubMed - indexed for MEDLINE]Related articles

    35.

    Intravenous diltiazem and CYP3A-mediated metabolism.

    Masica AL, Azie NE, Brater DC, Hall SD, Jones DR.

    Br J Clin Pharmacol. 2000 Sep;50(3):273-6.PMID: 10971313 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.

    Swan SK, Rudy DW, Lasseter KC, Ryan CF, Buechel KL, Lambrecht LJ, Pinto MB, Dilzer SC, Obrda O, Sundblad KJ, Gumbs CP, Ebel DL, Quan H, Larson PJ, Schwartz JI, Musliner TA, Gertz BJ, Brater DC, Yao SL.

    Ann Intern Med. 2000 Jul 4;133(1):1-9.PMID: 10877734 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Clinical pharmacology in the Middle Ages: principles that presage the 21st century.

    Brater DC, Daly WJ.

    Clin Pharmacol Ther. 2000 May;67(5):447-50. No abstract available. PMID: 10824622 [PubMed - indexed for MEDLINE]Related articles

    38.

    Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome.

    Agarwal R, Gorski JC, Sundblad K, Brater DC.

    J Am Soc Nephrol. 2000 Jun;11(6):1100-5.PMID: 10820174 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    The interaction of diltiazem with simvastatin.

    Mousa O, Brater DC, Sunblad KJ, Hall SD.

    Clin Pharmacol Ther. 2000 Mar;67(3):267-74.PMID: 10741630 [PubMed - indexed for MEDLINE]Related articles

    40.

    Pharmacology of diuretics.

    Brater DC.

    Am J Med Sci. 2000 Jan;319(1):38-50. Review.PMID: 10653443 [PubMed - indexed for MEDLINE]Related articles

    41.

    Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition.

    Brater DC.

    Am J Med. 1999 Dec 13;107(6A):65S-70S; discussion 70S-71S. Review.PMID: 10628595 [PubMed - indexed for MEDLINE]Related articles

    42.

    Use of diuretics in cirrhosis and nephrotic syndrome.

    Brater DC.

    Semin Nephrol. 1999 Nov;19(6):575-80. Review.PMID: 10598545 [PubMed - indexed for MEDLINE]Related articles

    43.

    Stereoselective pharmacokinetics of ketoprofen and ketoprofen glucuronide in end-stage renal disease: evidence for a 'futile cycle' of elimination.

    Grubb NG, Rudy DW, Brater DC, Hall SD.

    Br J Clin Pharmacol. 1999 Oct;48(4):494-500.PMID: 10583018 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    The interaction of diltiazem with lovastatin and pravastatin.

    Azie NE, Brater DC, Becker PA, Jones DR, Hall SD.

    Clin Pharmacol Ther. 1998 Oct;64(4):369-77.PMID: 9797793 [PubMed - indexed for MEDLINE]Related articles

    45.

    Diuretic therapy.

    Brater DC.

    N Engl J Med. 1998 Aug 6;339(6):387-95. Review. No abstract available. PMID: 9691107 [PubMed - indexed for MEDLINE]Related articles

    46.

    Role of duration of diuretic effect in preventing sodium retention.

    Ferguson JA, Sundblad KJ, Becker PK, Gorski JC, Rudy DW, Brater DC.

    Clin Pharmacol Ther. 1997 Aug;62(2):203-8.PMID: 9284857 [PubMed - indexed for MEDLINE]Related articles

    47.

    The effect of nonsteroidal antiinflammatory drugs on electrolyte homeostasis and blood pressure in young and elderly persons with and without renal insufficiency.

    Murray MD, Lazaridis EN, Brizendine E, Haag K, Becker P, Brater DC.

    Am J Med Sci. 1997 Aug;314(2):80-8. No abstract available. PMID: 9258209 [PubMed - indexed for MEDLINE]Related articles

    48.

    Effects of NSAIDs on the kidney.

    Murray MD, Brater DC.

    Prog Drug Res. 1997;49:155-71. Review.PMID: 9388387 [PubMed - indexed for MEDLINE]Related articles

    49.

    Variable furosemide absorption and poor predictability of response in elderly patients.

    Murray MD, Haag KM, Black PK, Hall SD, Brater DC.

    Pharmacotherapy. 1997 Jan-Feb;17(1):98-106.PMID: 9017769 [PubMed - indexed for MEDLINE]Related articles

    50.

    Dopamine does not enhance furosemide-induced natriuresis in patients with congestive heart failure.

    Vargo DL, Brater DC, Rudy DW, Swan SK.

    J Am Soc Nephrol. 1996 Jul;7(7):1032-7.PMID: 8829118 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...